Barclays initiated coverage on Encompass Health with a new price target
$EHC
Hospital/Nursing Management
Health Care
Barclays initiated coverage of Encompass Health with a rating of Overweight and set a new price target of $95.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $115.00 | Overweight | KeyBanc Capital Markets |
| 7/10/2024 | $100.00 | Outperform | Leerink Partners |
| 3/6/2024 | $95.00 | Overweight | Barclays |
| 3/14/2023 | $57.00 | Equal Weight | Barclays |
| 2/7/2022 | $90.00 → $80.00 | Strong Buy | Raymond James |
| 11/3/2021 | $94.00 → $80.00 | Buy | Mizuho |
| 11/2/2021 | $107.00 → $90.00 | Strong Buy | Raymond James |
| 10/13/2021 | $100.00 → $88.00 | Buy | Truist Securities |
BIRMINGHAM, Ala., May 1, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on July 15, 2025, to holders of record on July 1, 2025. About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 167 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients
BIRMINGHAM, Ala., April 9, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it has changed the time of its 2025 first quarter earnings call from 10 a.m. ET to 9 a.m. ET on Friday, April 25, 2025. As previously announced, the Company will report results for its first quarter ended March 31, 2025, after the market closes on Thursday, April 24, 2025. The Company will host the investor conference call to discuss its results at 9 a.m. ET on Friday, April 25, 2025. The conference call may be accessed by dialing 800-245-3047 and providing the conference ID EHCQ1
BIRMINGHAM, Ala., April 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will report results for its first quarter ended March 31, 2025, after the market closes on Thursday, April 24, 2025. The Company will host an investor conference call at 10 a.m. ET on Friday, April 25, 2025, to discuss its results. The conference call may be accessed by dialing 800-245-3047 and providing the conference ID EHCQ125. International callers should dial 203-518-9765 and provide the same conference ID. Please call approximately 10 minutes before the start of the call
The Company will award research-funding grants totaling up to $60,000 BIRMINGHAM, Ala., May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept. 30, 2025, at 5 p.m. EST. The grants, totaling up to $60,000, will be awarded for the investigation of the impact or effectiveness of therapies in the inpatient rehabilitation facility post-acute care setting, knowledge translation or implementation science. Grant recipients do not have to be affiliated with Encompass Health and research does not have to be conducted in an Encompass Health inpatient rehabilitation hospital.
BIRMINGHAM, Ala., May 1, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on July 15, 2025, to holders of record on July 1, 2025. About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 167 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients
BIRMINGHAM, Ala., April 28, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced it will participate in the BofA Securities 2025 Healthcare Conference, which is being held May 13-15, 2025. Encompass Health's Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat on Tuesday, May 13, 2025, from 8:40-9:10 a.m. PT. The presentation will be webcast live and available at investor.encompasshealth.com. About Encompass HealthEncompass Health (NYSE:EHC) is the largest owner and operator of inpatient rehabilitation hospita
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
4 - Encompass Health Corp (0000785161) (Issuer)
8-K - Encompass Health Corp (0000785161) (Filer)
10-Q - Encompass Health Corp (0000785161) (Filer)
144 - Encompass Health Corp (0000785161) (Subject)
On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court
BIRMINGHAM, Ala., and JOHNSTON, R.I., July 30, 2024 /PRNewswire/ -- Today, Encompass Health (NYSE:EHC), the nation's largest owner and operator of rehabilitation hospitals, announced the opening of Encompass Health Rehabilitation Hospital of Johnston, a 50-bed inpatient rehabilitation hospital located at 2109 Hartford Avenue in Johnston, Rhode Island. The hospital provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients re
BIRMINGHAM, Ala., Nov. 27, 2023 /PRNewswire/ -- Encompass Health Corporation (NYSE:EHC) today announced the appointment of Edward M. Christie III to its board of directors. This appointment will expand the Encompass Health board to 12 director seats as part of its ongoing succession planning. Christie joins the Encompass Health board with significant experience in finance, strategic and public company leadership, operations, and governmental regulation. Christie currently serves as President and Chief Executive Officer of Spirit Airlines, Inc., a leading ultra low-cost carrier
KeyBanc Capital Markets initiated coverage of Encompass Health with a rating of Overweight and set a new price target of $115.00
Leerink Partners initiated coverage of Encompass Health with a rating of Outperform and set a new price target of $100.00
Barclays initiated coverage of Encompass Health with a rating of Overweight and set a new price target of $95.00
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G/A - Encompass Health Corp (0000785161) (Subject)
SC 13G - Encompass Health Corp (0000785161) (Subject)